BioSpace News Archive

Business

San Francisco 49ers, WellStrong Expand Physical Therapy And Sports Rehab Partnership To San Jose

Partnership adds second location with opening of West Coast Sports Institute

January 22, 2019
·
2 min read
Drug Development

Compugen Announces Publication of Two Peer-Reviewed Papers Demonstrating the Role of PVRIG as a Novel Immune Checkpoint for Cancer Immunotherapy

Data published in Cancer Immunology Research indicate monotherapy and combination opportunities for COM701, a first-in-class cancer immunotherapy antibody targeting PVRIG

January 22, 2019
·
5 min read
BioCapital

ACell Announces Participation in Arab Health 2019

ACell, Inc. announced their participation in Arab Health 2019, being held January 28-31 in Dubai. ACell will be part of the State of Maryland Delegation at the USA Partnership Pavilion.

January 22, 2019
·
1 min read
Genetown

Stepes Accelerates Medical Translations with AI

Leading enterprise language services provider helps global life sciences companies accelerate international drug and medical device development with artificial intelligence powered medical translation solutions.

January 22, 2019
·
2 min read
BioMidwest

FirstLight Home Care Named to Entrepreneur’s Franchise 500® for 2019

Award-winning provider of non-medical home care earns ranking for eighth straight year

January 22, 2019
·
2 min read
Immunochina Raises $20.4 Million USD in Series C Financing

Immunochina Pharmaceuticals today announced the closing of its $140 million RMB Series C financing

January 22, 2019
·
3 min read
Drug Development

Concert Pharmaceuticals Completes Enrollment of 12 mg Cohort in Phase 2a Trial of CTP-543 in Alopecia Areata

Concert Pharmaceuticals, Inc. today announced that it has completed patient enrollment of the final cohort evaluating 12 mg twice daily of CTP-543 in its Phase 2a trial for the treatment of moderate-to-severe alopecia areata.

January 22, 2019
·
5 min read
Policy

Rocket Pharmaceuticals Announces Clearance of IND for RP-A501 Gene Therapy for Danon Disease

Phase 1 Clinical Trial to Commence in the Second Quarter of 2019

January 22, 2019
·
6 min read
Drug Development

Aurinia Announces Voclosporin Ophthalmic Solution Demonstrates Statistically Superior Efficacy Versus Restasis® in a Phase 2 Head-to-Head Study for the Treatment of Dry Eye Syndrome

VOS showed statistical superiority to Restasis® on FDA-accepted objective signs of DES

January 22, 2019
·
10 min read
Deals

Tilray® to Acquire Natura Naturals Holdings Inc. for up to C$70 Million Subject to Performance Milestones

Acquisition increases the Company’s capacity to supply branded cannabis products

January 22, 2019
·
7 min read